Of note, we also observed that the expression difference across primary and metastatic tumors for PD‐L1 was associated with metastatic tumor timing; synchronous metastatic patients had larger differences between their primary and metastatic tumor pairs in comparison to metachronous metastatic patients. The gene discussed is CD274; the disease is metastatic neoplasm.